CRL
Charles River Laboratories International Inc
Price:  
193.55 
USD
Volume:  
417,130.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRL WACC - Weighted Average Cost of Capital

The WACC of Charles River Laboratories International Inc (CRL) is 8.0%.

The Cost of Equity of Charles River Laboratories International Inc (CRL) is 9.20%.
The Cost of Debt of Charles River Laboratories International Inc (CRL) is 4.45%.

Range Selected
Cost of equity 7.60% - 10.80% 9.20%
Tax rate 17.20% - 17.70% 17.45%
Cost of debt 4.00% - 4.90% 4.45%
WACC 6.7% - 9.3% 8.0%
WACC

CRL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.82 1.05
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 10.80%
Tax rate 17.20% 17.70%
Debt/Equity ratio 0.27 0.27
Cost of debt 4.00% 4.90%
After-tax WACC 6.7% 9.3%
Selected WACC 8.0%